AmacaThera Co-Founder, Dr. Molly Shoichet, Named 2019 Distinguished Woman

Dr. Molly Shoichet, Co-Founder of AmacaThera and Professor at the University of Toronto, has been named a 2019 Distinguished Woman in Chemistry or Chemical Engineering by the International Union of Pure and Applied Chemistry (IUPAC).

Click here to read more

Previous
Previous

MedStack Raises $2.4 Million Seed Round

Next
Next

OBIO Opens 2019 Niagara Investment Summit, Connecting Canada’s Most Promising Innovations with Leading Global Investors